Search research articles
Contact Us
Filters
Showing results (1-10 of 47) with videos related to
Page
of 5
Sort By:
Experimental Neurology
|
October 26, 2010
Recent advances in the development of immunotherapies for tauopathies
Kiren Ubhi, Eliezer Masliah
Journal of Alzheimer'S Disease : JAD
|
July 20, 2012
Alzheimer's disease: recent advances and future perspectives
Kiren Ubhi, Eliezer Masliah
Trends in Neurosciences
|
October 4, 2011
Multiple system atrophy: a clinical and neuropathological perspective
Kiren Ubhi, Phillip Low, Eliezer Masliah
Glia
|
December 7, 2013
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy
Elvira Valera, Kiren Ubhi, Michael Mante, et al.
Synapse (New York, N.Y.)
|
October 15, 2013
Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat
Rubén Antonio Vázquez-Roque, Kiren Ubhi, Eliezer Masliah, et al.
The FEBS Journal
|
April 17, 2009
Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's disease
Gideon M Shaked, Stephanie Chauv, Kiren Ubhi, et al.
Brain Pathology (Zurich, Switzerland)
|
December 14, 2011
Autophagy in dementias
Christine Lund Kragh, Kiren Ubhi, Tony Wyss-Coray, et al.
Neuroreport
|
February 9, 2012
Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy
Edward Rockenstein, Kiren Ubhi, Chandra Inglis, et al.
Neuroreport
|
March 13, 2010
Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy
Kiren Ubhi, Edward Rockenstein, Michael Mante, et al.
Journal of Alzheimer'S Disease : JAD
|
March 16, 2011
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease
Daniel Havas, Birgit Hutter-Paier, Kiren Ubhi, et al.
Page
of 5
Search research articles
Search
Showing results (1-10 of 47) with videos related to
Sort By:
Page
of 5
Experimental Neurology
|
October 26, 2010
Recent advances in the development of immunotherapies for tauopathies
Kiren Ubhi, Eliezer Masliah
Journal of Alzheimer'S Disease : JAD
|
July 20, 2012
Alzheimer's disease: recent advances and future perspectives
Kiren Ubhi, Eliezer Masliah
Trends in Neurosciences
|
October 4, 2011
Multiple system atrophy: a clinical and neuropathological perspective
Kiren Ubhi, Phillip Low, Eliezer Masliah
Glia
|
December 7, 2013
Antidepressants reduce neuroinflammatory responses and astroglial alpha-synuclein accumulation in a transgenic mouse model of multiple system atrophy
Elvira Valera, Kiren Ubhi, Michael Mante, et al.
Synapse (New York, N.Y.)
|
October 15, 2013
Chronic cerebrolysin administration attenuates neuronal abnormalities in the basolateral amygdala induced by neonatal ventral hippocampus lesion in the rat
Rubén Antonio Vázquez-Roque, Kiren Ubhi, Eliezer Masliah, et al.
The FEBS Journal
|
April 17, 2009
Interactions between the amyloid precursor protein C-terminal domain and G proteins mediate calcium dysregulation and amyloid beta toxicity in Alzheimer's disease
Gideon M Shaked, Stephanie Chauv, Kiren Ubhi, et al.
Brain Pathology (Zurich, Switzerland)
|
December 14, 2011
Autophagy in dementias
Christine Lund Kragh, Kiren Ubhi, Tony Wyss-Coray, et al.
Neuroreport
|
February 9, 2012
Neuronal to oligodendroglial α-synuclein redistribution in a double transgenic model of multiple system atrophy
Edward Rockenstein, Kiren Ubhi, Chandra Inglis, et al.
Neuroreport
|
March 13, 2010
Alpha-synuclein deficient mice are resistant to toxin-induced multiple system atrophy
Kiren Ubhi, Edward Rockenstein, Michael Mante, et al.
Journal of Alzheimer'S Disease : JAD
|
March 16, 2011
A longitudinal study of behavioral deficits in an AβPP transgenic mouse model of Alzheimer's disease
Daniel Havas, Birgit Hutter-Paier, Kiren Ubhi, et al.
Page
of 5